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ABSTRACT 
Background: Early diagnosis and treatment of leukemia patients remains a fundamental aim in clinical 
oncology, especially in developing country. Present study highlights the basic requirements of these patients 
in Iran. Better understanding of these issues may lead to improve the healthcare standards toward leukemia 
diagnosis and treatment.  
Methods: This descriptive study included 101 specialists in hematology-oncology and pathology serving in 
oncology centers. The participants were then asked to fill out a standard questionnaire on the issues around 
diagnosis and treatment of blood malignancies. 
Results: According to specialists, unfair distribution of facilities across the country, delayed diagnosis of 
disease, absence of psychological support for patients, and insufficient financial support were the main 
reasons of inappropriate diagnosis and treatment in leukemia patients.  
Conclusions: Our results show that making an amendment to health policies by preparing well-equipped 
medical centers in all provinces, improving the morale of patients through consultation during the process of 
treatment, and above all, subsiding leukemia patients' financial problems will promote the health standard 
regarding the leukemia diagnosis and treatment in Iran. 
 




   After cardiovascular diseases, cancers are the 
second most common cause of mortality in 
developed countries, and the third in 
underdeveloped countries. The significance of 
cancers as a major health problem has been 
revealed by the increasing incidence over the world 
by which the economic and psychological status of 
families can be affected.1 Statistically, the rate of 
cancers in Iran is increasing and it is much higher 
than standard levels.2,3 According to the Iranian 
Ministry of Health (2007), exclusively based on the 
report of Pathology Center, cancers of skin, breast, 
stomach, colorectal, liver, hematopoietic system, 
esophagus, prostate, lung, brain, and the central 
nervous system (CNS) are the most prevalent 
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malignancies in Iran.1,4 Leukemia is located in the 
sixth position of this classification by 5.76% 
incidence range.2  The exact frequency of leukemia 
is unclear because of the absence of bone 
marrow biopsy or aspiration availability, especially 
for children, leading to create falsely low statistics 
of leukemia.2 Therefore, the early diagnosis and 
control of leukemia are essential to prevent   
progression of disease. This can be fulfilled by 
regular screening as a key factor in the ultimate 
management of diagnostic and therapeutic 
processes for leukemia patients.5 
   Patients suffering from leukemia have different 
predicaments which can be classified as 
psychological and physical. It is obvious that these 
two main problems should be resolved in parallel in 
order to overcome this debilitating disease.6-8 
Psychological needs include supportive and intimate 
relationship with medical staff,9 paying more 
attention to the mental state of patients for 
maintaining their spirits and trying to enable them 
to deal with the new situation.10 Physical 
requirements consist of diagnostic tests and 
treatment facilities, professional medical teams, 
diagnosis and treatment of disease and also their 
treatment costs. Due to the different requirements 
of leukemia patients, it is essential to scrutinize the 
weak points of healthcare system regarding 
leukemia diagnosis and therapeutic standards.11  It 
is essential to say that for such patients, preparing 
the basic requirements is more important than 
advanced needs.12 The present study has been 
designed to evaluate the deficiencies in diagnosis 
and treatment of leukemia in Iran by emphasis on 
the psychological and physical demands of leukemia 
patients according to the viewpoint of local 
specialists. Clear understanding of system defects in 
leukemia diagnosis and treatment may lead to take 
much better policies in order to confront these 
obstacles.  
  
SUBJECTS AND METHODS 
   A designed questionnaire, which its validity and 
reliability was confirmed, has been applied in this 
study. Content-related validity was confirmed based 
on the specialist's opinions and the latest 
editions of hematology text books. Moreover, 
reliability of the test was considered 0.80 by using 
Cronbach's alpha, which indicated the high internal 
consistency coefficient of these questions. 
In this descriptive study, 101 hemato-oncologists 
and pathologists serving in medical centers and 
universities were selected by random cluster 
sampling method. A questionnaire was classified 
into two categories according to the previous 
studies. In the first category, demographic data 
including age, sex, province, university and last 
degree were recorded and in the second part 
fifteen questions were noted down on paper 
regarding to leukemia diagnosis and treatment. The 
questions focused on the following issues: 
   Availability of diagnostic-therapeutic standards, 
scientific progress in diagnosis and treatment 
procedure, available facilities, medical ethics, 
defects involved the leukemia diagnosis and 
treatment, scientific level of diagnostic team, 
information and financial status of patients in 
improvement of treatment procedure, the 
satisfaction of leukemia patients with therapy and 
their tendency toward going abroad (without 
considering their economic situation), mental status 
of patients during treatment process, time span 
from patient admission to beginning the treatment,  
accuracy and precision of clinical and laboratory 
examinations for leukemia diagnosis, reliability of 
leukemia diagnosis methods in comparison with 
current methods performed over the world, and, at 
the end, the most common leukemia diagnosis 
methods in Iran. It should be noted that all 
questions had 3 or 5 choices and were designed to 
compare national standards with global standards. 
The study analyzed the data with SPSS software by 
means of a chi-square test.  
 
RESULTS 
   In this study, we aimed to evaluate the main 
challenges in diagnosis and treatment of leukemia 
patients. The age range of the participants in this 
study was between 29 and 72 years old (mean: 
43.22 years) of whom 62.2% were male and 37. 8% 
were female. Moreover, hemato-oncologists and 
pathologists consisted 85.15% and 14.85% of this 
selected group, respectively.  Information of     
triple-choice questions and their results are 
indicated in Table 1. According to the results, 
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almost 61% of participants claimed that leukemia 
diagnostic procedures do not comply with 
international standards, 23% mentioned that the 
leukemia diagnostic procedure is not thoroughly 
acceptable in Iran and 16% asserted that the 
standard procedures are not performed at all. with 
the perspective of specialist regarding leukemia 
research, approximately the same results were 
obtained; 69% of the specialists believed that poor 
condition made early diagnosis and more effective 
treatment difficult or impossible in Iran. 
   Comparison of diagnostic equipment in Iran with 
developed countries showed considerable results. 
In fact, only 13% of participants in the second-and 
third-ranked university agreed with appropriateness 
of existing standards, whereas 65% disagreed. The 
details of information about diagnostic equipment 
and methods are shown in Table 2. Regarding 
academic standards, the majority of participants 
had a positive response to the question. According 
to the participants’ responses, awareness and 
economic situation of patients were 78% and 81%, 
respectively. However, according to the poor 
condition, paying attention to patient’s mental 
health during treatment course may bring 
promising results.  
   So that 11% of participants chosen "Yes", 42% 
“somewhat” and 48% “No”. The most common 
answers to this question whether the elapsed time 
from the onset of leukemia to definite diagnosis 
and treatment initiation is the same as international 
standard levels were negative. On the other hand, 
accuracy and validity of the diagnostic results were 
acceptable compared with developed countries. 




Table 1: Statements related to triple-choice questions about diagnostic standard levels, awareness and economic situation of leukemia 
patients
 
   Table 2 shows the items related to five-choice                                                                                                                                                                            
questions. Satisfaction of leukemia patients and 
their tendency to go abroad for better diagnosis, 
treatment, and monitoring are major issues 
discussed in this step. According to participants, 
there was a high inclination toward pursuing 
treatment process abroad (regardless of their 
financial status). Nearly 68% of participants chose 
“high” and 15% “very high” option, respectively. 












 % number % number % number % number 
100 101 61.4 62 15.8 16 22.8 23 leukemia diagnosis procedures  in Iran compared with 
developed countries 
100 100 69 69 17 17 14 14 Leukemia research trend in Iran compared with the growing 
global trend 
100 101 65.3 66 21.8 22 12.9 13 Comparison of diagnosis and treatment facilities of 
leukemia in Iran with developed countries 
100 99 5.1 5 51.5 51 43.4 43 Respect  to the medical ethics by leukemia diagnosis and 
treatment team in Iran 
100 100 3 3 24 24 73 73 Comparison of academic standard level of leukemia 
diagnosis and treatment teams  in Iran with developed 
countries 
100 101 1.98 2 19.8 20 78.2 79 Effect  of patients’ awareness about leukemia on the 
diagnosis and treatment procedure 
100 100 2 2 17 17 81 81 Effect  of economic situation  of patients in diagnosis and 
treatment procedure of leukemia 
100 100 27 27 53 53 20 20 Treatment costs  
100 99 48.5 48 42.4 42 11.1 11 Paying attention to patient’s mental health during the 
treatment procedure 
100 100 58 58 35 35 7 7 Elapsed time from disease onset to initiation of treatment in 
Iran vs. developed countries 
100 99 6.1 6 21.2 21 72.7 72 Validity and reliability of leukemia diagnosis in Iran in 
comparison with developed countries 
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Table 2: Items related to the five-choice questions on leukemia 
patient satisfaction rates 
 
 
   According to study participants, peripheral blood 
morphology is the most common method to 
detect leukemia throughout the country, and then 
it is followed by bone marrow morphology and 
clinical findings. Also, the participants mentioned 
that flow cytometry is another important method 
for leukemia diagnosis, especially in case of acute 
leukemia. On the other hand, all participants cited 
that peripheral blood, BM morphology and clinical 
findings were easily accessible diagnostic 
procedures, but the accessibility of flow cytometry, 
molecular genetics and cytogenetic techniques 
were confirmed by 37%, 17.8% and 8.9% of 
participants, respectively.  
   Only 7.9% of the participants confirmed that all 
above-mentioned diagnostic procedures were 
available in their facilities. Peripheral blood, BM 
morphology and clinical findings are available 
diagnostic methods in our cities, but none of the 
other methods listed in Table 3 were accessible. 
Nowadays, flow cytometry is currently the most 
common method for diagnosis of leukemia. In 
towns, the samples are frequently sent to larger 
cities for flow cytometric analysis but only the 
towns that are near big cities like Tehran have this 
chance and remote towns have serious problems. 
 
DISCUSSION 
   In this study, we aimed to design and explore a 
new kind of research which is based on medical 
specialist views about the present issues in 
diagnosis and treatment procedures of leukemia 
patients. Findings revealed that the most important 
problem is the shortage of equipment and unequal 
distribution of facilities throughout the country, 
especially for flow cytometric analysis, molecular 
studies and cytogenetic assessment. For example, 
molecular studies are just performed in major cities 
such as Tehran, Isfahan, Mashhad, Shiraz, Kerman 
and Tabriz (although not perfectly), whereas small 
cities lacking adequate facilities must send their 
samples to larger ones for analysis, which can be a 
waste of money and time. Moreover, it can prolong 
the process of diagnosis and delay the treatment, 
resulting in significant effect on therapeutic 
outcome in leukemia patients and making diagnosis 
difficult in Iran.  
   In general, economic problems and sanctions are 
the most important reasons for current shortage of 
equipment. Another finding was about the time 
elapsed from diagnosis of leukemia to initiation of 
therapy in Iran compared with developed countries. 
The 35% of specialists who were primarily 
employed at top-ranked universities in large cities 
expressed that this period of time is relatively 
favorable, and 58% (at Second- and third- ranked 
universities) declared unacceptable. These findings 
are consistent with findings of facility shortage.  
   Obviously, there is a direct correlation between 
available facilities and the span of time between 
patient admission and definite diagnosis. According 
to our survey, even in major cities, there are only a 
few well-equipped centers.  
   In this study, only 7.9% of the participants stated 
that they had full access to all necessary equipment 
in their centers, viewing diagnostic process as 
favorable to developed countries. One of the main 
reasons that reduce the chance of treatment for 
acute leukemia patients in Iran is maybe the lack of 
a screening system for punctilious diagnosis. In 
other words, the average rate of timely diagnosis 















of going abroad 
for treatment 




interest of   
going abroad  
for treatment 
Very high Number 6 15 
% 6.1 15.2 
High Number 11 67 
% 11.1 67.7 
Moderate Number 42 8 
% 42.4 8.1 
Low Number 30 4 
% 30.3 4 
Very low Number 10 5 
% 10.1 5.1 
Total  Number 99 99 
% 100 100 
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Table 3: Items related to five-choice questions on topics of common diagnostic methods and the overall availability of diagnostic methods 
             *Participants could choose more than one option 
 
causing poor outcomes. Another question that was 
considered in the questionnaire was about the 
optimization of leukemia diagnosis and treatment 
procedures in Iran compared with global state. The 
69% of specialists replied in the negative and 
asserted that the existing trend is unfavorable. The 
results regarding the question which underscored 
the availability of research facilities in academia 
indicated that slow rate of leukemia investigations 
in Iran is probably associated with economic 
problems and sanctions which directly affect the 
quality and quantity of existing research facilities.  
Another question was regarding the patient’s 
mental health during the treatment course. Only 
11% of specialists replied positive to the question 
and 48% chose the "No" answer, which seems to be 
reasonable. Thus, psychologists, social workers and 
counselors may have a profound impact on the 
treatment course. Accumulating evidence has 
demonstrated the dramatic effects of psychological 
 
issues on cancer patients13 Remmers et al. (2010) 
considered the emotional support as an  urgent 
requirement for women with breast cancer.14 
Heydari et al. (2009) stated that constructing social 
support network for cancer patients via support 
groups including physicians, nurses and relatives or 
friends of patients is important.15 Interestingly, the 
most important point in increasing the                  
self-confidence and improving mental state of 
patients is drawing their attention to spiritual 
matters. Tatsumura et al. (2002) indicated that 
cancer patients who rely on spiritual and religious 
beliefs can better handle the stress of illness during 
the treatment course.16 Additionally, Harandi et al. 
(2010) concluded that paying more attention to 
emotional, social and mental health of patients are 
beneficial for patients.11 Taghavi et al. (2011) 
showed that Cancer Support Community is a source 
of social support along with other resources17 and 
can be helpful in terms of both emotional and 
      Answers                           Option item Most common diagnostic methods *Availability of diagnostic methods 
Peripheral blood 
morphology 
Number 36 101 
% 36 100 
BM morphology Number 30 101 
% 30 100 
Clinical findings Number 28 101 
% 28 100 
Flow cytometric 
analysis 
Number 4 37 
% 4 36.6 
Molecular studies Number 1 18 
% 1 17.8 
Cytogenetic Number 1 9 
% 1 8.9 
All items Number 0 8 
% 0 7.9 
Total participants Number 100 101 
% 100 100 
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financial support for cancer patients.  Various 
societies are active in this field in Iran but it seems 
that their activity is not enough to fill the existing 
gaps. The study of Harandi et al. (2010) confirmed 
that one of the basic problems in cancer patients is 
the lack of associations and institutions to support 
those requirements.11 The charitable activities of 
these associations cannot satisfy our expectations, 
so effective government agencies are required to 
meet the ends and fill the gaps. Ismaili et al. (2010) 
showed that aid organizations (government,      non-
government and community-based organizations) 
can make a major contribution in response to 
patients' needs.18 Financial support provided by 
these organizations, including health insurance, will 
be crucial and decisive, especially in the diagnosis 
and treatment of cancer. Another part of our study 
focused on the answer to this question whether 
patients' knowledge about leukemia has effect on 
timely diagnosis and treatment. Based on the 
results obtained in this study, 78% 
of the participants replied positive to the 
question. Our findings show that patients' 
knowledge has an important role in the timely 
diagnosis and treatment of the disease. Therefore, 
the patient’s knowledge about their treatment 
course is an important requirement for diagnosis 
and another aspect of protecting leukemia patients. 
Jenkins et al. (2001) stated that most patients tend 
to receive much more information in relation to the 
disease and its treatment.19 Drageset et al. (2010) 
concluded that information about the disease from 
medical or other sources is helpful for cancer 
patients.20 Esbebsen et al. (2010) found that lack of 
information may guide patients to unreliable 
sources of information about their disease.21 Our 
study also demonstrated that the poor economic 
condition of leukemia patients along with other 
problems is one of their major predicaments. 
According to the Yan and Sellick. (2004) financial 
issues and mental health counseling are important 
to deal with the concerns of cancer patients.22 We 
found that one of the fundamental problems in 
leukemia patients is overwhelming costs they spend 
for diagnosis and treatment in Iran. 
   Present study is the first investigation of this kind 
in Iran. But the exact correlation between these 
problems and mortality or remission of patients has 
suffered most neglect and needs most detailed 
scrutiny. Knowing the gaps and deficiencies allows 
us to develop healthcare strategic plans. It is 
obvious that resolving current problems and filling 
the existing gaps will improve health standards in 
the future.  
 
CONCLUSION 
   Making an amendment to the policies governing 
the healthcare system should lead to fair 
distribution of facilities across the country, 
acceptable attention to the mental state of patients 
by therapist and appropriate counseling centers 
during the treatment process, and ultimately 
financial support of government and non-
government organizations for leukemia patients, 
especially low-income families, will certainly pave 
the way to achieve the much better health 
standards regarding the leukemia diagnosis and 
treatment in Iran. 
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